Latest From Itochu Corp.
AgomAb, CinCor and Confo Therapeutics secure Series A financing, while AlloVir closes a $121m Series B and more venture financing in April and May.
Private Company Edition: Former Juno execs launch allogeneic cell therapy venture Sana, Atlas raises a $250m fund, and the Rakuten Aspyrian, Apollomics and Antengene VC deals exceed the $100m mark.
A plethora of personnel changes is taking place in the pharmaceutical industry around Asia as a new year arrives.
The firm's so-called Project Atlantic radiation therapy system combines high-field real-time MR imaging with state-of-the-art linear technology that Elekta says will take the standard of care to the next level. It is aiming for European and U.S. approvals in 2017.
- Therapeutic Areas
- C. Itoh & Co. Ltd
- Pacific Rim
- Parent & Subsidiaries
- Itochu Corp.
- Senior Management
Eizo Kobayashi, Pres. & CEO
Kouhei Watanabe, CFO
- Contact Info
Phone: (81) 3 3497 2121
5-1, Kita-Aoyama 2-chome
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.